However, therapeutic doses for treating deficiency and associated nerve damage are substantially higher
these usually present in infancy, although neurologic and psychiatric presentations of cobalamin C defect have been described in adolescents and adults (216
Taylor EL, Armstrong KR, Perrett D, Hattersley AT, Winyard PG
16, Sonthalia, Sidharth, et al
Tirzepatide is a dual GLP-1 and GIP receptor agonist that requires proper reconstitution before injection
The ultimate goal is to generate clinical evidence that leads to official changes in treatment guidelines, ensuring that injection frequency is based on patient-reported symptoms and individual clinical response, rather than solely on national blanket protocols